Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Global Vaccine Market Outlook to 2020

4. Major Vaccines: Current and Future Market Analysis
     4.1 Pneumococcal
     4.2 Influenza
     4.3 Cancer
     4.4 Polio
     4.5 Varicella
     4.6 Rotavirus
     4.7 Meningococcal
     4.8 DTP
     4.9 Hepatitis
     4.10 Measles, Mumps, and Rubella (MMR)
     4.11 Japanese Encephalitis
     4.12 Tuberculosis
     4.13 Malaria
     4.14 Rabies
     4.15 Typhoid
     4.16 HIV

5. Key Geographical Markets
     5.1 US
     5.2 Europe
     5.3 Japan
     5.4 China
     5.5 India
     5.6 Brazil

6. Pipeline Analysis

7. Competitive Landscape
     7.1 GSK
            7.1.1 Business Overview
            7.1.2 Vaccine Portfolio & Pipeline
            7.1.3 Strengths and Weaknesses
     7.2 Sanofi-Pasteur
            7.2.1 Business Overview
            7.2.2 Vaccine Portfolio & Pipeline
            7.2.3 Strengths and Weaknesses
     7.3 Pfizer
            7.3.1 Business Overview
            7.3.2 Vaccine Portfolio & Pipeline
            7.3.3 Strengths and Weaknesses
     7.4 Merck
            7.4.1 Business Overview
            7.4.2 Vaccine Portfolio & Pipeline
            7.4.3 Strengths and Weaknesses
     7.5 Novartis
            7.5.1 Business Overview
            7.5.2 Vaccine Portfolio & Pipeline
            7.5.3 Strengths and Weaknesses
     7.6 Emergent Biosolutions
            7.6.1 Business Overview
            7.6.2 Vaccine Portfolio & Pipeline
            7.6.3 Strengths and Weaknesses
     7.7 AstraZeneca Plc.
            7.7.1 Business Overview
            7.7.2 Vaccine Portfolio & Pipeline
            7.7.3 Strengths and Weaknesses
     7.8 Baxter International Inc.
            7.8.1 Business Overview
            7.8.2 Vaccine Portfolio & Pipeline
            7.8.3 Strengths and Weaknesses
     7.9 BioCSL (CSL Biotherapies)
            7.9.1 Business Overview
            7.9.2 Vaccine Portfolio & Pipeline
            7.9.3 Strengths and Weaknesses
     7.10 Dendreon Corporation
            7.10.1 Business Overview
            7.10.2 Vaccine Portfolio & Pipeline
            7.10.3 Strengths and Weaknesses
     7.11 Takeda Pharmaceutical Company Limited
            7.11.1 Business Overview
            7.11.2 Vaccine Portfolio & Pipeline
            7.11.3 Strengths and Weaknesses
     7.12 Crucell
            7.12.1 Business Overview
            7.12.2 Vaccine Portfolio & Pipeline
            7.12.3 Strengths and Weaknesses